Monday, 14 December 2020

Tavistock puberty blocker study published after nine years

Tavistock puberty blocker study published after nine years All but one child treated for gender dysphoria with puberty-blocking drugs at a leading NHS clinic also received cross-sex hormones, a study has shown.

The Tavistock and Portman Trust has argued the treatments are not linked.

The High Court ruled last week that under-16s are unlikely to be able to give informed consent to be treated with puberty-blocking drugs. BBC News

See also:

No comments:

Post a Comment